No Data
OptimizeRx | 10-Q: Quarterly report
OptimizeRx Price Target Raised to $16.00/Share From $15.00 by JMP Securities
OptimizeRx Price Target Raised to $16.00/Share From $15.00 by JMP Securities
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.Bolt Biotherapeutics posted a GAAP loss of 28 cent
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersSINTX Techs (NASDAQ:SINT) stock moved upwards by 136.2% to $0.13 during Wednesday's regular session. The company's market cap stands at $15.9 million. The company's, Q1 earnings came out 2 days
Express News | OptimizeRx Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
Expert Ratings For OptimizeRx
OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of their re